Pharmacology Quiz
19 questions · no time limit
0:00
ONCOLOGY & IMMUNOLOGY PHARMACOLOGY
Question 1 of 19
No time limit
Current
Answered
Flagged
Not seen
PASSAGE
A 72-year-old patient with metastatic colorectal cancer is started on a FOLFIRI chemotherapy regimen plus bevacizumab. The patient has a history of well-controlled hypertension managed with a single agent.
Given the addition of bevacizumab, which of the following sets of parameters requires the most vigilant monitoring due to the drug's specific mechanism-related toxicities?
YOUR PROGRESS
19
QUESTIONS
Ready when you are
Answer in any order. Your progress shows here as you go.
QUESTIONS
KEYBOARD
Pick an answer ABCD
Next question ↵→
Previous ←
Flag for review F
Answers save as you go · flagged questions come back at the end